Clinical, Radiological Features and Treatment Outcomes of Tuberculosis in Patients Aged 75 years and Older

Author:

Alsehali Afrah1,Alrajeh Haneen1,AL-Jahdali Hamdan2,Al-Safi Eiman3,Layqah Laila4,Baharoon Salim2

Affiliation:

1. College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

2. King Abdulaziz Medical City

3. Minsirty of Health, Al-Yamama Hospital Riyadh Second Health Cluster Saudi Arabia

4. Research Offices, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Abstract

Abstract Introduction Tuberculosis is a significant contributor of morbidity and mortality. With a progressively aging population, TB is increasingly encountered in older adults. Understanding the clinical presentation and optimal treatment strategies for TB in this population is essential. Method Clinical, radiological features, treatment and outcome of TB in patients aged 75 years or older was evaluated retrospectively. Results Among 92 elderly tuberculosis patients, most were male (76.1%) with a mean age of 82.5 years. Pulmonary TB was diagnosed in 52.2% of patients, Extra Pulmonary TB in 32.6%, and Disseminated TB in 15.2%. Comorbidities included Diabetes Mellitus (59.8%) and Congestive Heart Failure (41.3%). The most common presentation symptoms included cough (51.1%), fever (43.5%), dyspnea (39.1%), and weight loss (31.5%). Delay of TB diagnosis for up to 3 months was observed in 31.5% of patients. Weight loss and male gender were significant predictors of delayed diagnosis. Laboratory findings varied among TB types, with disseminated TB showing higher eosinophilia and thrombocytopenia. Completion of an initial RIPE treatment protocol achieved in 67.6% of patients. Mortality during treatment occurred in 23.9% of patients. Pulmonary TB was associated with higher mortality compared to extrapulmonary TB (p=0.007). Conclusion Tuberculosis is associated with high mortality in patients above age of 75. There is still a substantial delay in TB diagnosis in elderly. RIPE regimen is frequently changed due to side effect. Alternative regimen choices were quite variable. More studies on tuberculosis in this patient’s population is needed to define the best effective therapeutic approach.

Publisher

Research Square Platform LLC

Reference57 articles.

1. W. H. O. (WHO). Global Tuberculosis Report 2013. http://www.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf?ua=1. (accessed.

2. W. H. O. (WHO.). Global Tuberculosis Report 2019. https://www.who.int/docs/default-source/documents/tuberculosis/global-tb-report-2019-advocacy-toolkit.pdf?sfvrsn=6bb15fcb_1 (accessed.

3. Oseran AS et al. Long term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort study, (in eng), Bmj, vol. 382, p. e076222, Aug 9 2023, 10.1136/bmj-2023-076222.

4. Rahevar K, Fujiwara PI, Ahmadova S, Morishita F, Reichman LB. Implementing the End TB Strategy in the Western Pacific Region: Translating vision into reality, (in eng), Respirology, vol. 23, no. 8, pp. 735–742, Aug 2018, 10.1111/resp.13308.

5. Bright A, Denholm J, Coulter C, Waring J, Stapledon R. Tuberculosis notifications in Australia, 2015–2018, Communicable Diseases Intelligence (2018), vol. 44, 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3